Benchling is the leader in cloud-based informatics for life sciences R&D. The company offers a unified platform purpose-built for biologics R&D, from early discovery through bioprocessing. The platform consists of six natively unified applications that drive scientist productivity and unlock business insights for managers and executives: Notebook, Molecular Biology, Registry, Inventory, Workflows, and Requests.
Benchling is built specifically for the complexity of large molecules and large molecule R&D workflows. Users can model and interconnect any large molecule, from DNA fragments, to bispecifics, to cell lines, and see every experiment where they were ever used, alongside the results they produced. The system also empowers organizations to structure any large molecule R&D process – from screening, to purification, to cell line development – into step-by-step workflows. Benchling clients take advantage of the platform's point-and-click flexibility to test new process variations and experimental conditions.
Ultimately, clients report productivity increases of more than 2x compared with legacy systems, as well as a 66% reduction in email-based research collaboration. Managers and executives leverage Benchling's analytics and dashboards capabilities to back up key business decisions such as candidate selection, process optimization, and resource allocation. And with the system's exposed REST APIs and webhooks, IT teams build instrument integrations and completely novel applications into Benchling.
More than 150,000 scientists across 164 countries now rely on Benchling to power their research. After implementing the system at more than 120 biologics R&D organizations from emerging biotechs to top 20 pharma, Benchling has seen more than 99% client renewals year-over-year.
There are two parts to the Festival of Biologics: three conferences covering Antibodies, Immunotherapy, Biosimilars and an exhibition featuring solutions for pharma and biotech.